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PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY AND STENTING OF
EXTRACRANIAL VERTEBRAL ARTERY STENOSES
Isabelle P henry1, Amira Benjelloun2, Michel C. Henry3
1Polyclinique Bois Bernard, BOIS BERNARD, France, 2Clinique Coeur et Vaisseaux,
RABAT, Morocco, 3Cabinet de cardiologie, nancy, France
Background: To evaluate the safety and efﬁciency of vertebral angioplasty and
stenting (VAS) in symptomatic patients.
Methods: 102 angioplasties in 96 pts (M:72) mean age 68,3  6,7 years (22-84) left
58. All pts had multivascular diseases: carotid (CA):63, subclavian (SA): 26, coro-
nary:64.. Atheromatous lesions: 100, inﬂammatory: 2. Mean lesion length: 9,6 +/-
2,8 mm. Mean % stenosis 83.2  7.7, mean arterial diameter : 4,8  0,6 mm (4-6). 94
lesions at VO segment (ostium), 6 at V1 and 2 at V2 segments. Indications for
angioplasty: dizziness (96), bilateral weakness (11), visual changes (11), diplopia (10),
drop attacks (20), TIA (13), ataxia (5). A protection device (ﬁlter) used in 10 pts. 20
SA angioplasties performed at the same time of VAS, 8 CA. All angioplasties per-
formed by femoral approach, 4 by brachial approaches after failure of femoral
approach. (2 successes).
Results: Technical success 100/102 (98%). 6 lesions treated by angioplasty alone: 3
VO (ﬁrst 3 pts. 2 V1, 1 V2 lesion). 1 pt (inﬂammatory disease) treated by cutting
balloon alone. 93 lesions treated with stents (direct stenting: 78). Peripheral balloon
expandable stents (n¼23), self expandable stents (n¼4 for 3 V1 and one V2 lesions).
70 coronary stents (14 DES). 1 pt developed a TIA during the procedure. No
neurological complications at 30 days Clinical success 94/96 (98%) Post-procedure
arterial diameter: 4,55  0,8 mm (4-6). Mean residual stenosis 2,2  3,5 %. In 10 pts
treated with protection devices, visible debris removed in 7 (5 Filterwire, 2 Fibernet)
with the same amount of debris as during Carotid Stenting) 7 pts (8%) developed
a symptomatic restenosis during the follow-up (mean: 31.4.28.9 months), 3 after
PTA alone, 4 after PTA and stent (1 occlusion treated medically, 6 stenoses
successfully treated with PTA). No restenosis after DES implantation at 1 year.
Conclusions: VAS can be performed safely and effectively with a high technical
success rate, a low complication rate, a low restenosis rate and a durable clinical
success in patients with symptomatic VA stenosis. Stents seem to improve immediate
and long-term results. The role of protection devices and D.E.S has to be discussed
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Rick R. McClure1, William Brooks2, Michael R. Jones3
1University of KY, Lexington, KY, 2Central Baptist Hospital, Lexington, KY, 3Central
Baptist Hospital, lexington, KY
Background:Modern clinical trials with short-term follow-up indicate CAS and CEA
are equivalent in reducing the risk for ipsilateral ischemic stroke secondary to carotid
stenosis. A paucity of data exists regarding long term outcomes.
Methods: Patients with symptomatic and asymptomatic of all surgical risks with
carotid stenosis (>70%) were randomly selected for CEA or CAS and followed
a minimum of ten years.
Results: Long-term follow up was achieved in 173 patients (91%). Eighty-seven
(50.2%) died within this period, most commonly of non-vascular causes. No differ-
ences in occurrence and/or risk of stroke ipsilateral to the treated artery was noted
among treatment groups (p¼0.61). Restenosis determined by sequential ultrasound
was seen only in the CAS group (3.3%) and remained asymptomatic. The combined
risk of fatal or non-fatal heart attack was highest in individuals with symptomatic
compared to asymptomatic stenosis. (27.5% vs. 11.0%; p¼<0.05)) and was higher in
all patients treated with CEA (p¼0.02).
Conclusions: Long-term protection against ipsilateral stroke provided by CAS and
CEA is equivalent. The 10 year risk of fatal/non-fatal myocardial infarction is highest
in all patients harboring symptomatic carotid stenosis at enrollment however the risks
of fatal/non-fatal heart attack are much more prevalent in all patients, symptomatic and
asymptomatic, randomized to CEA.JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrTCT-503
The Challenge of Left Internal Carotid Stenosis Stenting and Bovine Aortic Arch
(BAAC):Systematic Right Radial or Brachial Approach in 60 Consecutive
Patients
piero montorsi1, Stefano Galli1, Paolo M. Ravagnani1, Daniela Trabattoni1,
Giovanni Ballerini1, Franco Fabbiocchi1, Alessandro Lualdi1, Daniele Andreini1,
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Background: BAAC refers either to left common carotid artery (LCCA) origin from
the innominate artery (type 2) or from a common origin from the aorta (type
1).When left internal carotid artery(LICA)stenosis is present,CAS from the femoral
approach may be difﬁcult, increasing the risk of technical failure and cerebral
embolization.
Methods: Between 2007 and 2012, 60/505 (11.8%) consecutive pts with LICA
stenosis and BAAC underwent CAS with cerebral protection from right radial or
brachial approach. Type of cerebral protection (distal vs. proximal), stent (open vs.
closed cell design) and technique (direct stenting vs. predilation) were left at oper-
ation's discretion. Double antiplatelet treatment was maintained up to 3 months after
CAS. Procedural variables such as ﬂuoroscopy time, radiation exposure, contrast
medium and technical failure were compared to that of a comparable group of 13 pts
with BAAC undergoing CAS by femoral catheterization.
Results: Type 2 BAAC was present in 86% of pts. The mean age was 739 years
(>75 years, 45%).Male gender was 73%,75% had high-surgical-risk characteristics
and 83% were asymptomatic. Radial or brachial approach was used in 54% and 46%
of pts, respectively. Technical success was 98.3% (1 pt crossed over to femoral
approach). Clinical success was 96.7% (1 retinal embolism and 1 minor stroke).
Proximal protection (8FMO.MA) was used in 15 cases (11 brachial,4 radial) with 1
device failure (shift to ﬁlter) and 100% procedural and 100% clinical successes.
Vascular complications occurred in 2/0 pts in the brachial/radial group, respectively.
No major bleeding occurred. Fluoroscopy time (p<0.05),contrast medium (p<0.03),
radiation exposure (p¼0.08) and technical failure (1.6% vs. 16.6%,p¼0.06) were
reduced as compared to femoral catheterization.
Conclusions: CAS through right radial or brachial approach is safe and effective in
pts with LICA stenosis and BAAC. Advantages over femoral approach include:
avoidance of aortic arch, favorable anatomic pathway for LCCA cannulation, choice
between two arterial accesses, use of proximal protection, low bleeding and vascular
complication rates (especially from the radial approach) and early patients'
ambulation.TCT-504
Randomized comparison of transradial and transfemoral approach for carotid
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Background: Limited data exist on radial access in carotid artery stenting (CAS).
This multicenter prospective randomized study was performed to compare the
outcome and complication rate of transradial (TR) and transfemoral (TF) CAS.
Methods: The clinical and angiographic data of 260 consecutive patients high risk for
carotid endarterectomy (CEA) treated by CAS with cerebral protection between 2010
and 2012 were evaluated. Patients were randomized to TR (n ¼130) or TF (n ¼130)
groups and several parameters were evaluated: Primary endpoint: MACCE, rate of
access site complications. Secondary endpoint: angiographic outcome of the CAS,
ﬂuoroscopy time and X Ray dose, procedural time, cross over rate to another puncture
site and hospitalisation in days.
Results: Procedural success was achieved in 260 patients (100%), the cross over rate
was 10 % in the TR and 1.5% in the TF group (p<0.05). Major access site compli-
cation was encountered in 1 patient (0.9%) in the TR and in 1 patient (0.8%) in the TF
group (p¼ns). The incidence of MACCE was 0.9% in the TR and 0.8% in the TF
group (p¼ns). Procedure time (1744742 vs. 1665744 sec, p¼ns) and ﬂuoroscopy
time (613289 vs. 579285 sec, p¼ns) was not signiﬁcantly different, but the
radiation dose was signiﬁcantly higher in the TR group (223138 vs.
182106Gycm2, p<0.05).
Conclusions: The transradial approach for carotide artery stenting has the same
efﬁcacy and safety as transfemoral, however the cross over rate and radiation dose is
higher and hospitalisation is shorter with transradial access.acts/POSTER/Carotid and Neurovascular Intervention B153
Table I. Demographic and clinical data
Demographic and clinical data of all study patients
Radial group
(n=130)
Femoral group
(n=130) P value
Age 66.88.9 66.710.2 0.856
Male (%) 60.8 65.4 0.441
Hypertension (%) 77.7 88.5 0.021
Hyperlipidaemia
(%)
56.2 47.7 0.172
Diabetes mellitus
(%)
36.2 36.9 0.898
Obesity (%) 14.6 34.6 0.0003
Smoker (%) 28.5 26.9 0.889
Peripheral artery
disease (%)
13.9 13.8 1.000
Coronary artery
disease (%)
24.6 24.6 0.776
Positive family
history (%)
6.9 9.2 0.495
Dialysis (%) 6.2 3.1 0.237
TUESDAY, OCTOBER 29, 2013, 3:30 PM–5:30 PM www.jacctctabstracts2013.com
P
O
S
T
E
R
STCT-505
Impact of coronary artery disease presence on the long-term follow-up of carotid
artery stenting
Salech Arif1, Stanislaw Bartus1, Artur Dziewierz1, Tomasz Rakowski1,
Michał Brzezinski1, Michał Chyrchel1, Dariusz Dudek1
1University Hospital, Krakow, Poland
Background: Carotid artery stenting (CAS) has become an alternative for carotid
endarterectomy in the treatment of carotid arteries atherosclerosis due to low
procedural injury and comparable procedural risk. Patients with coronary artery
disease have a higher risk of surgical treatment than in CAS procedure. The impact
of coronary artery disease (CAD) during long term follow-up (FU) needs reconsi-
dering due to the intensiﬁcation of aggressive pharmacotherapy in CAD during
recent years.
Methods: Data of 130 symptomatic and asymptomatic patients undergoing CAS
from January 2002 to December 2010 were divided in two groups: with and without
CAD. All CAS procedures were performed with application of cerebral protection
devices. Major adverse cardio and cerebrovascular events (MACCE) during follow-
up were deﬁned as combination of death (cardiac and non-cardiac), myocardial
infarction and stroke/TIA. Long-term outcomes of patients were stratiﬁed based on
history of CAD.
Results: The mean age of patients was 669 years, majority of patients were male
(80.2%). Long-term follow-up data were available in 86.2% of patients. During mean
follow-up of 71.931.7 months all-cause mortality rate was 19.6%. The rates of
myocardial infarction, stroke/TIA, and MACCE - were 14.3%, 11.6%, and 37.5%
respectively. The frequency of MACCE during long-term follow-up was higher in
patients with CAD vs without CAD (40.8% vs 6.7%,p ¼ 0.01) and the mortality rate
in the two groups was (22.2% vs 0%, p ¼ 0.07) respectively.
Conclusions: Patients with symptomatic or asymptomatic carotid stenosis are a high-
risk individuals with many coexisting diseases. The presence of CAD increases the
risk of MACCE in such patients during long-term follow-up.
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Background: Current guidelines recommend to perform Carotid Artery Stenting
(CAS) procedures with embolic protection devices (EPDs). Among these, prox-
imal EPDs such as the endovascular clamping (MO.MA. Medtronic INC) have the
advantage of providing embolic protection during all phases of the intervention.
However, endovascular clamping of the common carotid artery can expose theB154 JACC Vol 62/18/Suppl B j October 27–November 1, 2ipsilateral hemisphere to hypoperfusion and produce transient neurological
symptoms (clamping intolerance). The aim of the present study was to identify
the predictors of developing carotid clamping intolerance during CAS with
MO.MA.
Methods: From March 2010 to March 2012, 605 consecutive patients underwent
CAS using MO.MA. as EPD at our institution. Clamping intolerance was deﬁned as
any transient neurological deﬁcit observed during occlusion time, but showing
a complete recovery within 20 min after restoring antegrade ﬂow. To identify
predictors of clamping intolerance a logistic regression model was developed
including all patients' clinical characteristics, the presence of ICA stenosis >90%, the
presence of ipsilateral ECA stenosis, the presence of contralateral ICA stenosis (75-
99%) and occlusion, clamping pressure 40 mmHg, and arterial pressure delta >50
mmHg.
Results: 184 patients (30.4%) developed clamping intolerance during the CAS
procedure. Compared to patients without clamping intolerance, those who experienced
intolerance showed a lower clamping pressure (42.312.7 vs 61.9 5.4 mmHg,
p<0.001). ROC curve analysis showed that clamping pressure was the most consistent
predictor with a c-statistic of 0.85 (95% CI 0.82-0.88) and best cut-off being 40
mmHg (sensitivity 68.5%, speciﬁcity 93.3%). Logistic regression analysis showed
that the most powerful independent predictor of clamping intolerance was a clamping
pressure 40 mmHg (HR¼34.2, 95% CI 19.7-59.6) and that the most powerful
clinical predictor of such clamping pressure was the presence of contralateral ICA
occlusion (HR¼3.1, 95% CI 1.5-6.2).
Conclusions: Clamping intolerance may occur in up to a third of the patients
undergoing CAS with endovascular clamping. This event is more common in those
patients presenting a clamping pressure 40 mmHg.
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Background: It is not known whether racial or ethnic disparities observed with other
revascularization procedures are also seen with carotid artery stenting (CAS) and
endarterectomy (CEA).
Methods: We compared the utilization of CAS and CEA across racial/ethnic groups
within the CARE Registry between May 2005 - Dec 2012. Differences in clinical
characteristics, procedural variables, and major adverse cardiac and cerebrovascular
events (MACCE) were studied.
Results: Between 2005 and 2012, of the 13,129 patients who underwent CAS,
majority were non-Hispanic Caucasians (NHC 89.3%), followed by African Ameri-
cans (AA 4.4%), Hispanics (H 4.3%), and other groups (OG 2.0%). A similar
distribution was observed among the 10,953 patients undergoing CEA (NHC 92.6%,
AA 3.5%, H 2.8%, and OG 1.1%). During this time period, a trend toward propor-
tionate increase in CAS utilization was observed in NHC and OG whereas the
opposite was observed among H and AA (Fig 1). This trend persisted even when
hospitals performing both CAS and CEA were exclusively analyzed. Adherence to
anti-platelet and statin therapy was signiﬁcantly lower among AA post-CEA. In-
hospital MACCE remained comparable across groups post-CAS whereas post CEA,
there was a signiﬁcant decline in MACCE among NHC only (p¼0.04). At 30 days, the
incidence of death (2.2%), stroke (7.2%), and MACCE (8.8%) was higher among AA
post-CEA (p<0.05).013 j TCT Abstracts/POSTER/Carotid and Neurovascular Intervention
